Effect of Chemotherapy on Pain Sensitivity and Patient-reported Symptoms
Completed
Conditions studied: Breast Cancer, Chronic Pain
In brief
Many breast cancer survivors report chronic pain that develops or worsens following chemotherapy. The impact of chemotherapy on the development of chronic pain is uncertain. In this proposal, we are studying the impact of chemotherapy on a patient's sensitivity to pain. We are also investigating whether a patient's sensitivity to pain is related to how many symptoms she experiences during treatment.
Key facts
- Study ID
- NCT01983982
- Run by
- University of Michigan
- People needed
- 30
- Starts
- 2013-11-01
- Expected to finish
- 2016-01-01
- Last updated by the study team
- 2016-07-26
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female gender
- Histologically proven stage I-III invasive carcinoma of the breast who is planning to receive a standard dose of adjuvant chemotherapy.
- Surgical resection should be complete at the time of study enrollment.
- Eastern Cooperative Oncology Group performance status 0-2.
You may not qualify if…
- Average pain over the past 24 hours of 4 or greater on a 0-10 scale.
- Peripheral sensory neuropathy grade 2 or higher.
- Personal history of schizophrenia or major depressive disorder, or history of suicidal ideation or attempt within the past 2 years.
- Thumbnail abnormalities on either hand (such as artificial nails) that are likely to alter pain perception during testing.
- Pregnant or nursing.
- No prior chemotherapy for any reason
Where it is running
- University of Michigan Health System — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.